[Skip navigation] FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
 HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule

Approvals - August 2004

  ANDA Number Generic Drug Name Applicant Approval Date
1 76-422 CICLOPIROX TOPICAL SUSPENSION USP, 0.77% (LOTION) 0.77%   ALTANA, INC. 8/6/2004 
2 75-115 NITROGLYCERIN TRANSDERMAL SYSTEM 0.2 MG/HOUR AND 0.4 MG/HOUR   SCHWARZ PHARMA, INC. 8/10/2004 
3 76-323 ESMOLOL HYDROCHLORIDE INJECTION 10 MG/ML; PACKAGED IN 100 MG/10 ML SINGLE-DOSE VIALS   BEDFORD LABORATORIES 8/10/2004 
4 76-851 LEVOCARNITINE ORAL SOLUTION, USP 1 G/10 ML   LYNE LABORATORIES, INC. 8/10/2004 
5 40-612 METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION, USP 1 GRAM (BASE)/VIAL   AMERICAN PHARMACEUTICAL PARTNERS, INC. 8/12/2004 
6 76-368 POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS, USP 20 mEq   EURAND INC. 8/18/2004 
7 76-414 MILRINONE LACTATE IN 5% DEXTROSE INJECTION 20 MG (BASE)/100 ML SINGLE-DOSE PLASTIC CONTAINER   B. BRAUN MEDICAL, INC. 8/18/2004 
8 77-025 NITROFURANTOIN CAPSULES, USP (MACROCRYSTALS) 100 MG   MYLAN PHARMACEUTICALS, INC. 8/18/2004 
9 75-728 LORATADINE ORAL SOLUTION, USP (OTC) 5 MG/5 ML   L. PERRIGO COMPANY 8/20/2004 
10 75-815 LORATADINE ORAL SOLUTION, USP (OTC) 5 MG/5 ML   MORTON GROVE PHARMACEUTICALS, INC. 8/20/2004 
11 76-529 LORATADINE ORAL SOLUTION, USP (OTC) 5 MG/5 ML   RANBAXY LABORATORIES LIMITED 8/20/2004 
12 76-792 METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE TABLETS, USP 50 MG/25 MG, 100 MG/25 MG, AND 100 MG/50 MG   MYLAN PHARMACEUTICALS, INC. 8/20/2004 
13 76-805 LORATADINE ORAL SOLUTION, USP (OTC) 5 MG/5 ML   TARO PHARMACEUTICAL INDUSTRIES LTD. 8/20/2004 
14 76-239 MINOXIDIL TOPICAL SOLUTION, USP (FOR MEN) (OTC) 5%   HARMONY LABS, INC. 8/24/2004 
15 76-774 HALOPERIDOL INJECTION, USP (PRESERVATIVE-FREE) 5 MG (BASE)/ML; PACKAGED IN 5 MG (BASE)/1 ML SYRINGES   APOTEX CORP. 8/25/2004 
16 76-791 HALOPERIDOL INJECTION, USP (PRESERVATIVE-FREE) 5 MG (BASE)/ML; PACKAGED IN 5 MG (BASE)/1 ML SINGLE-USE VIALS   APOTEX CORP. 8/25/2004 
17 76-814 DEXTROAMPHETAMINE SULFATE EXTENDED-RELEASE CAPSULES 5 MG, 10 MG, AND 15 MG   ABLE LABORATORIES, INC. 8/25/2004 
18 76-828 HALOPERIDOL INJECTION, USP 5 MG (BASE)/ML; PACKAGED IN 50 MG (BASE)/10 ML MULTIPLE-DOSE VIALS   APOTEX CORP. 8/25/2004 
19 76-870 ALLOPURINOL SODIUM FOR INJECTION 500 MG (BASE)/VIAL   BEDFORD LABORATORIES 8/26/2004 
20 40-564 DOXYLAMINE SUCCINATE TABLETS, USP (OTC) 25 MG   LNK INTERNATIONAL, INC. 8/27/2004 
21 76-699 CARBIDOPA AND LEVODOPA ORALLY DISINTEGRATING TABLETS 10 MG/100 MG, 25 MG/100 MG, AND 25 MG/250 MG   SCHWARZ PHARMA, INC. 8/27/2004 
22 76-830 OFLOXACIN OPHTHALMIC SOLUTION, USP 0.3%   PHARMAFORCE, INC. 8/31/2004 

Back to Top      Back to Approvals

Date created: September 8, 2004

horizonal rule

CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility | HHS Home Page

FDA/Center for Drug Evaluation and Research